Skip to main content
About
Contact
Subscribe
e-Edition
Make Home Page
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Twitter
Toggle navigation
Site search
Search
Home
Contact Us
Advertise
Subscription Services
Promote Your Event
Submission Forms
News
Local News
National
World
Archives
Sports
Local Sports
National Sports
Business
Local Business
National Business
Technology
Markets & Stocks
Opinion
Columns
Editorials
Letters To The Editor
Polls
Thumbs
A & E
Local Entertainment
Art Scene
Music Scene
Theatre Scene
Book Reviews
Movie Reviews
TV Listings
Local Events
What To Do
Life
Health
Travel
Oddities
Community Directory
Community Service
Rescue Me
Other
Magazines
Fall Home Improvements
Women
Home & Realty
Outdoor Guide
Premier Home Style Tour 2024
Spring Home & Garden Show
Spring on the Road
Spring Wellness
Classifieds
Place Ad
Careers
Tenders
Weather
Obituaries
Parcel Pickup
2024 Readersâ Choice
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Trevi Therapeutics Inc
(NQ:
TRVI
)
2.730
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EST, Nov 21, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
0
Open
2.730
Bid (Size)
2.500 (2)
Ask (Size)
2.780 (2)
Prev. Close
2.730
Today's Range
2.730 - 2.730
52wk Range
0.9700 - 4.000
Shares Outstanding
60,069,512
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Why Trevi Therapeutics Could Be a Triple-Bagger Biotech Stock
September 06, 2024
Wall Street analysts see big potential upside for small-cap biopharma firm Trevi Therapeutics. So, what does the firm do and how does it stand out?
Via
MarketBeat
Exposures
Product Safety
TRVI Stock Earnings: Trevi Therapeutics Misses EPS for Q2 2024
August 08, 2024
TRVI stock results show that Trevi Therapeutics missed analyst estimates for earnings per share the second quarter of 2024.
Via
InvestorPlace
Performance
YTD
+110.00%
+110.00%
1 Month
-15.48%
-15.48%
3 Month
-1.09%
-1.09%
6 Month
+7.48%
+7.48%
1 Year
+139.47%
+139.47%
More News
Read More
12 Health Care Stocks Moving In Thursday's After-Market Session
June 06, 2024
Via
Benzinga
TRVI Stock Earnings: Trevi Therapeutics Misses EPS for Q1 2024
May 07, 2024
Via
InvestorPlace
TRVI Stock Earnings: Trevi Therapeutics Beats EPS for Q4 2023
March 20, 2024
Via
InvestorPlace
Trevi Therapeutics: Q4 Earnings Insights
March 20, 2024
Via
Benzinga
Earnings Outlook For Trevi Therapeutics
March 19, 2024
Via
Benzinga
Trevi Therapeutics's Earnings: A Preview
November 08, 2023
Via
Benzinga
Recap: Trevi Therapeutics Q1 Earnings
May 11, 2023
Via
Benzinga
Earnings Scheduled For March 20, 2024
March 20, 2024
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
August 01, 2023
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
April 18, 2023
Via
Benzinga
Earnings Outlook For Trevi Therapeutics
March 15, 2023
Via
Benzinga
Earnings Scheduled For November 9, 2023
November 09, 2023
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
April 18, 2023
Via
Benzinga
Earnings Scheduled For August 10, 2023
August 10, 2023
Via
Benzinga
Earnings Preview: Trevi Therapeutics
May 10, 2023
Via
Benzinga
Earnings Scheduled For May 11, 2023
May 11, 2023
Via
Benzinga
Earnings Scheduled For March 16, 2023
March 16, 2023
Via
Benzinga
Why Glory Star New Media Group Shares Are Trading Higher By 122%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
April 18, 2023
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For March 14, 2023
March 14, 2023
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For April 12, 2023
April 12, 2023
Via
Benzinga
Trevi Therapeutics, Inc. Discusses Progress and 2022 Success of Clinical Studies for Its Investigational Oral Therapy Haduvio(TM) with The Stock Day Podcast
January 25, 2023
Via
Newsfile
Why Manchester United Shares Are Trading Higher By Around 10%; Here Are 20 Stocks Moving Premarket
November 23, 2022
Via
Benzinga
Earnings Scheduled For November 10, 2022
November 10, 2022
Via
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.